– USA, IN – Zimmer Biomet Holdings, Inc. (NYSE: ZBH / SIX: ZBH), a global medical technology leader, announced the appointment of Dev Kurdikar to its Board of Directors, effective immediately.
“We are pleased to welcome Dev to the ZB Board,” said Chris Begley, Chairman of the Company’s Board of Directors. “Dev brings a wealth of medtech, innovation and leadership experience that will be invaluable to ZB as we further advance our strategic priorities and mission to alleviate pain and improve peoples’ lives.”
About Devdatt Kurdikar
Dev Kurdikar has served as the President and CEO and a member of the board of directors of embecta since its spinoff from BD on April 1, 2022. He was the Worldwide President of Diabetes Care at BD from 2021 until the spinoff. Before joining BD, Mr. Kurdikar was President and CEO of Cardiac Science Corporation from 2016 to 2019. Before that role, Mr. Kurdikar was VP and GM of Men’s Health, within Urology and Pelvic Health at Boston Scientific Corporation (Boston Scientific) from 2015 to 2016. Mr. Kurdikar served in the same role at American Medical Systems starting in 2013 and led the Men’s Health business through its carve-out, sale, and integration into Boston Scientific. Before joining AMS, Mr. Kurdikar worked for 11 years with Baxter International, Inc., holding leadership roles of increasing responsibility in finance, strategy and integration, R&D planning, and operations, ultimately serving as VP of Marketing, from 2011 through 2013. He began his career as a Senior Research Engineer at The Monsanto Company.
Dev Kurdikar holds a Bachelor in Chemical Engineering from the University of Bombay (India). He earned a Master of Science in Chemical Engineering from Washington State University, a Ph.D. from Purdue University, and a Master of Business Administration from Washington University. Dev Kurdikar serves on the board of directors of AdvaMed.
About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics, and artificial intelligence.
With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.
For more: https://www.zimmerbiomet.com/en
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.